Title : Treatment with pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer: a multicenter real-world study.

Pub. Date : 2022

PMID : 35356262






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Specifically, this study investigated the efficacy of pyrotinib-based therapy in lapatinib-resistant HER2-positive metastatic breast cancer (NCT04899128). Lapatinib erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Conclusion: Pyrotinib-based therapy has the potential to improve survival in patients with lapatinib-resistant HER2-positive metastatic breast cancer, including those with brain metastases. Lapatinib erb-b2 receptor tyrosine kinase 2 Homo sapiens